Oral exposure to immunostimulating drugs results in early changes in innate immune parameters in the spleen

References

• Albers R, Broeders A, van der Pijl A, Seinen W, Pieters R. 1997. The use of reporter antigens in the popliteal lymph node assay to assess immunomodulation by chemicals. Toxicol Appl Pharmacol. 143:102–109.
   PubMed Web of Science ®Google Scholar
• Antoine DJ, Williams DP, Park BK. 2008. Understanding the role of reactive metabolites in drug-induced hepatotoxicity: state of the science. Expert Opin Drug Metab Toxicol. 4:1415–1427.
   PubMed Web of Science ®Google Scholar
• Beeler A, Engler O, Gerber BO, Pichler WJ. 2006. Long-lasting reactivity and high frequency of drug-specific T-cells after severe systemic drug hypersensitivity reactions. J Allergy Clin Immunol. 117:455–462.
   PubMed Web of Science ®Google Scholar
• Boelsterli UA. 2003. Diclofenac-induced liver injury: A paradigm of idiosyncratic drug toxicity. Toxicol Appl Pharmacol. 192:307–322.
   PubMed Web of Science ®Google Scholar
• Bol-Schoenmakers M, Bleumink R, Marcondes Rezende M, Mouser E, Hassing I, Ludwig I, Smit J, Pieters R. 2011. Diclofenac enhances allergic responses in a mouse peanut allergy model. Clin Exp Allergy. 41:424–433.
   PubMed Web of Science ®Google Scholar
• Deng X, Luyendyk JP, Ganey PE, Roth RA. 2009. Inflammatory stress and idiosyncratic hepatotoxicity: Hints from animal models. Pharmacol Rev. 61:262–282.
   PubMed Web of Science ®Google Scholar
• Deng X, Stachlewitz RF, Liguori MJ, Blomme EA, Waring JF, Luyendyk JP. 2006. Modest inflammation enhances diclofenac hepatotoxicity in rats: Role of neutrophils and bacterial translocation. J Pharmacol Exp Ther. 319:1191–1199.
   PubMed Web of Science ®Google Scholar
• Gutting BW, Schomaker SJ, Kaplan AH, Amacher DE. 1999. A comparison of the direct and reporter antigen popliteal lymph node assay for the detection of immunomodulation by low molecular weight compounds. Toxicol Sci. 51:71–79.
   PubMed Web of Science ®Google Scholar
• Gutting BW, Updyke LW, Amacher DE. 2002. Investigating the TNP-OVA and direct popliteal lymph node assays for the detection of immunostimulation by drugs associated with anaphylaxis in humans. J Appl Toxicol. 22:177–183.
   PubMed Web of Science ®Google Scholar
• Higuchi S, Yano A, Takai S, Tsuneyama K, Fukami T, Nakajima M, Yokoi T. 2012. Metabolic activation and inflammation reactions involved in carbamazepine-induced liver injury. Toxicol Sci. 130:4–16.
   PubMed Web of Science ®Google Scholar
• James LP, Mayeux PR, Hinson JA. 2003. Acetaminophen-induced hepatotoxicity. Drug Metab Disp. 31:1499–1506.
   PubMed Web of Science ®Google Scholar
• Ju C, Uetrecht JP. 1999. Detection of 2-hydroxyiminostilbene in urine of patients taking carbamazepine and its oxidation to a reactive iminoquinone intermediate. J Pharmacol Exp Ther. 288:51–56.
   PubMed Web of Science ®Google Scholar
• Kaplowitz N. 2005. Idiosyncratic drug hepatotoxicity. Nat Rev Drug Discov. 4:489–499.
   PubMed Web of Science ®Google Scholar
• Kwast LM, Fiechter D, Hassing I, Bleumink R, Boon L, Ludwig IS, Pieters RHH. 2011. Oral exposure to drugs with immune-adjuvant potential induces hypersensitivity responses to the reporter antigen TNP-OVA. Toxicol Sci. 121:312–319.
   PubMed Web of Science ®Google Scholar
• Lillibridge JH, Amore BM, Slattery JT, Kalhorn TF, Nelson SD, Finnell RH, Bennett GD. 1996. Protein-reactive metabolites of carbamazepine in mouse liver microsomes. Drug Metab Disp. 24:509–514.
   PubMed Web of Science ®Google Scholar
• Luyendyk JP, Lehman-McKeeman LD, Nelson DM, Bhaskaran VM, Reilly TP, Car BD, Cantor GH, Maddox JF, Ganey PE, Roth RA. 2006. Coagulation-dependent gene expression and liver injury in rats given lipopolysaccharide with ranitidine but not with famotidine. J Pharmacol Exp Ther. 317:635–643.
   PubMed Web of Science ®Google Scholar
• Masson MJ, Carpenter LD, Graf ML, Pohl LR. 2008. Pathogenic role of natural killer T- and natural killer cells in acetaminophen-induced liver injury in mice is dependent on the presence of dimethyl sulfoxide. Hepatology. 48:889–897.
   PubMed Web of Science ®Google Scholar
• Naisbitt DJ, Britschgi M, Wong G, Farrell J, Depta JP, Chadwick DW, Pichler WJ, Pirmohamed M, Park BK. 2003. Hypersensitivity reactions to carbamazepine: Characterization of the specificity, phenotype, and cytokine profile of drug-specific T-cell clones. Mol Pharmacol. 63:732–741.
   PubMed Web of Science ®Google Scholar
• Naisbitt DJ, Sanderson LS, Meng X, Stachulski AV, Clarke SE, Park BK. 2007. Investigation of the immunogenicity of diclofenac and diclofenac metabolites. Toxicol Lett. 168:45–50.
   PubMed Web of Science ®Google Scholar
• Naisbitt DJ, Williams DP, Pirmohamed M, Kitteringham NR, Park BK. 2001. Reactive metabolites and their role in drug reactions. Curr Opin Allergy Clin Immunol. 1:317–325.
   PubMed Web of Science ®Google Scholar
• Nierkens S, Aalbers M, Bleumink R, Boon L, Pieters R. 2005a. Drug-induced Type 1 and Type 2 immune responses are characterized by distinct profiles of cell kinetics, cytokine production, and expression of co-stimulatory molecules in the popliteal lymph node assay. J Immunotoxicol. 2:141–150.
   PubMedGoogle Scholar
• Nierkens S, Aalbers M, Bol M, Bleumink R, van Kooten P, Boon L, Pieters R. 2005b. Differential requirement for CD28/CTLA-4-CD80/CD86 interactions in drug-induced Type 1 and Type 2 immune responses to tri-nitrophenyl-ovalbumin. J Immunol. 175:3707–3714.
   PubMed Web of Science ®Google Scholar
• Nierkens S, Aalbers M, Bol M, van Wijk F, Hassing I, Pieters R. 2005c. Development of an oral exposure mouse model to predict drug-induced hypersensitivity reactions by using reporter antigens. Toxicol Sci. 83:273–281.
   PubMed Web of Science ®Google Scholar
• Nierkens S, Nieuwenhuijsen L, Thomas M, Pieters R. 2004. Evaluation of the use of reporter antigens in an auricular lymph node assay to assess immunosensitizing potential of drugs. Toxicol Sci. 79:90–97.
   PubMed Web of Science ®Google Scholar
• Njoku DB. 2010. Suppressive and pro-inflammatory roles for IL-4 in the pathogenesis of experimental drug-induced liver injury: A review. Expert Opin Drug Metab Toxicol. 6:519–531.
   PubMed Web of Science ®Google Scholar
• Park BK, Laverty H, Srivastava A, Antoine DJ, Naisbitt D, Williams DP. 2011. Drug bioactivation and protein adduct formation in the pathogenesis of drug-induced toxicity. Chem-Biol Interact. 192:30–36.
   PubMed Web of Science ®Google Scholar
• Pieters R, Albers R. 1999. Assessment of autoimmunogenic potential of xenobiotics using the popliteal lymph node assay. Methods. 19:71–77.
   PubMed Web of Science ®Google Scholar
• Pirmohamed M, Naisbitt DJ, Gordon F, Park BK. 2002. The danger hypothesis: Potential role in idiosyncratic drug reactions. Toxicology. 181:55–63.
   PubMed Web of Science ®Google Scholar
• Rashed MS, Myers TG, Nelson SD. 1990. Hepatic protein arylation, glutathione depletion, and metabolite profiles of acetaminophen and a non-hepatotoxic regioisomer, 3′-hydroxyacetanilide, in the mouse. Drug Metab Disp. 18:765–770.
   PubMed Web of Science ®Google Scholar
• Roberts SA, Price VF, Jollow DJ. 1990. Acetaminophen structure-toxicity studies: In vivo covalent binding of a nonhepatotoxic analog, 3-hydroxyacetanilide. Toxicol Appl Pharmacol. 105:195–208.
   PubMed Web of Science ®Google Scholar
• Roychowdhury S, Svensson CK. 2005. Mechanisms of drug-induced delayed-type hypersensitivity reactions in the skin. AAPS J. 7:E834–846.
   PubMed Web of Science ®Google Scholar
• Rubinstein E. 2001. History of quinolones and their side-effects. Chemotherapy. 47(Suppl 3):3–8.
   PubMed Web of Science ®Google Scholar
• Schmid DA, Depta JP, Pichler WJ. 2006. T-Cell-mediated hypersensitivity to quinolones: Mechanisms and cross-reactivity. Clin Exp Allergy. 36:59–69.
   PubMed Web of Science ®Google Scholar
• Seguin B, Uetrecht J. 2003. The Danger Hypothesis applied to idiosyncratic drug reactions. Curr Opin Allergy Clin Immunol. 3:235–242.
   PubMed Web of Science ®Google Scholar
• Shaw PJ, Beggs KM, Sparkenbaugh EM, Dugan CM, Ganey PE, Roth RA. 2009a. Trovafloxacin enhances TNF-induced inflammatory stress and cell death signaling and reduces TNF clearance in a murine model of idiosyncratic hepatotoxicity. Toxicol Sci. 111:288–301.
   PubMed Web of Science ®Google Scholar
• Shaw PJ, Ditewig AC, Waring JF, Liguori MJ, Blomme EA, Ganey PE, Roth RA. 2009b. Co-exposure of mice to trovafloxacin and lipopolysaccharide, a model of idiosyncratic hepatotoxicity, results in a unique gene expression profile and IFNγ-dependent liver injury. Toxicol Sci. 107:270–280.
   PubMed Web of Science ®Google Scholar
• Shaw PJ, Ganey PE, Roth RA. 2010. Idiosyncratic drug-induced liver injury and role of inflammatory stress with an emphasis on an animal model of trovafloxacin hepatotoxicity. Toxicol Sci. 118:7–18.
   PubMed Web of Science ®Google Scholar
• Shaw PJ, Hopfensperger MJ, Ganey PE, Roth RA. 2007. Lipopolysaccharide and trovafloxacin co-exposure in mice causes idiosyncrasy-like liver injury dependent on TNFα. Toxicol Sci. 100:259–266.
   PubMed Web of Science ®Google Scholar
• Switzar L, Kwast LM, Lingeman H, Giera M, Pieters RH, Niessen WM. 2013. Identification and quantification of drug-albumin adducts in serum samples from a drug exposure study in mice. J Chromatography B. 917:53–61.
   PubMed Web of Science ®Google Scholar
• Uetrecht J. 2008. Idiosyncratic drug reactions: Past, present, and future. Chem Res Toxicol. 21:84–92.
   PubMed Web of Science ®Google Scholar
• Weaver JL, Chapdelaine JM, Descotes J, Germolec D, Holsapple M, House R, Lebrec H, Meade J, Pieters R, Hastings KL, et al. 2005. Evaluation of a lymph node proliferation assay for its ability to detect pharmaceuticals with potential to cause immune-mediated drug reactions. J Immunotoxicol. 2:11–20.
   PubMedGoogle Scholar
• Wu Y, Sanderson JP, Farrell J, Drummond NS, Hanson A, Bowkett E, Berry N, Stachulski AV, Clarke SE, Pichler WJ, et al. 2006. Activation of T-cells by carbamazepine and carbamazepine metabolites. J Allergy Clin Immunol. 118:233–241.
   PubMed Web of Science ®Google Scholar
• Yano A, Higuchi S, Tsuneyama K, Fukami T, Nakajima M, Yokoi T. 2012. Involve-ment of immune-related factors in diclofenac-induced acute liver injury in mice. Toxicology. 293:107–114.
   PubMed Web of Science ®Google Scholar
• Zhang X, Liu F, Chen X, Zhu X, Uetrecht J. 2011. Involvement of the immune system in idiosyncratic drug reactions. Drug Metab Pharmacokinet. 26:47–59.
   PubMed Web of Science ®Google Scholar